Behavioral Activation Therapy Viable Option in Depression
Less expensive, more accessible than cognitive behavioral treatment, researchers say
Antimicrobial Rx Up With Hospitalization for Acute Mania
Increased rate of recent antimicrobial prescription for individuals hospitalized with acute mania
Antipsychotic Polypharmacy Has Prevalence of 12 Percent
Diagnosis of schizophrenia, length of stay of 90 days or more are strongest predictors of polypharmacy
Estradiol Doesn’t Boost Cognitive Function After Menopause
No differences noted with treatment in either early or late menopause
Buprenorphine-Naloxone Use in Medicare Patients Low
Prescribers represent less than 2 percent of the 381,575 prescribers with 56.5 million opioid claims
Health Expenditures Rising for Middle Class, Wealthy
But, since 2004, simultaneous decline in expenditures for the nonelderly poor
Rapid HIV Transmission Seen in Injection Drug Users in Rural U.S.
Indiana case offers a lesson for other rural communities
Medicare Spending Up for Decedents Versus Survivors
Average per capita spending for Medicare beneficiaries who died 4-fold higher than survivors
Implant Non-Inferior to Daily Pill for Opioid Dependence
Long-acting buprenorphine implant offers new treatment method for opioid, heroin addiction
Number of Practicing Psychiatrists Declining
Findings may explain patient reports of poor access to mental health care
